Search This Blog

Thursday, November 14, 2019

Aurinia Pharma EPS misses by $0.02, beats on revenue

Aurinia Pharma (NASDAQ:AUPH): Q3 GAAP EPS of -$0.21 misses by $0.02.
Revenue of $0.23M (-39.5% Y/Y) beats by $0.2M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)